Meta-analysis of 13 RCTs (504 adults having gastrointestinal cancer surgery): preoperative recombinant interleukin 2 vs control raised lymphocyte counts at 1 week and lowered surgical site (OR 0.13) and systemic infections (OR 0.25); no severe side effects were reported.
Meta-analysisn = 504
Horcicka et al. Effects of preoperative recombinant Interleukin 2-based immunomodulation on outcome after gastrointestinal cancer surgery: a systematic review and meta-analysis